1.7118
price down icon2.23%   -0.0782
 
loading
前日終値:
$1.79
開ける:
$1.775
24時間の取引高:
5,198
Relative Volume:
0.23
時価総額:
$182.47M
収益:
$47.04M
当期純損益:
$-63.98M
株価収益率:
-2.1228
EPS:
-0.8064
ネットキャッシュフロー:
$-34.39M
1週間 パフォーマンス:
-5.15%
1か月 パフォーマンス:
-19.35%
6か月 パフォーマンス:
-4.37%
1年 パフォーマンス:
-18.60%
1日の値動き範囲:
Value
$1.75
$1.8046
1週間の範囲:
Value
$1.75
$1.8989
52週間の値動き範囲:
Value
$1.29
$3.5107

Innate Pharma Adr Stock (IPHA) Company Profile

Name
名前
Innate Pharma Adr
Name
セクター
Healthcare (1163)
Name
電話
-
Name
住所
-
Name
職員
177
Name
Twitter
@InnatePharma
Name
次回の収益日
2024-09-12
Name
最新のSEC提出書
Name
IPHA's Discussions on Twitter

IPHA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IPHA
Innate Pharma Adr
1.75 182.47M 47.04M -63.98M -34.39M -0.8064
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
466.13 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
548.09 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
318.04 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
539.27 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
243.96 28.51B 3.81B -644.79M -669.77M -6.24

Innate Pharma Adr Stock (IPHA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-09-03 アップグレード SVB Leerink Mkt Perform → Outperform
2020-12-15 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-11-24 開始されました Goldman Neutral

Innate Pharma Adr (IPHA) 最新ニュース

pulisher
May 28, 2025

Why Kingsoft Cloud Holdings Stock Plummeted by Nearly 8% Today - The Globe and Mail

May 28, 2025
pulisher
May 13, 2025

Earnings call transcript: Innate Pharma Q1 2025 earnings reveal strategic focus By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Innate Pharma Q1 2025 earnings reveal strategic focus - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Innate Pharma Q1 2025 slides: pipeline advances and Sanofi partnership strengthen outlook - Investing.com

May 13, 2025
pulisher
May 13, 2025

Innate Pharma Q1 2025 slides: pipeline advances and Sanofi partnership strengthen outlook By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
Apr 30, 2025

Innate Pharma reports promising preclinical results for cancer drug IPH4502 By Investing.com - Investing.com India

Apr 30, 2025
pulisher
Apr 29, 2025

Innate Pharma stock surges on promising preclinical data By Investing.com - Investing.com South Africa

Apr 29, 2025
pulisher
Apr 29, 2025

Innate Pharma reports promising preclinical results for cancer drug IPH4502 - Investing.com

Apr 29, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains $11 target on Innate Pharma stock By Investing.com - Investing.com South Africa

Apr 24, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains $11 target on Innate Pharma stock - Investing.com

Apr 24, 2025
pulisher
Mar 28, 2025

H.C. Wainwright maintains Buy rating on Innate Pharma stock By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

H.C. Wainwright maintains Buy rating on Innate Pharma stock - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Innate Pharma Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Innate Pharma Q4 2024 sees strategic advances By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Innate Pharma Q4 2024 sees strategic advances - Investing.com

Mar 27, 2025
pulisher
Jan 17, 2025

Innate Pharma shares retain Buy rating on long-term strategy - Investing.com

Jan 17, 2025
pulisher
Dec 23, 2024

AZN Stock Price and Chart — LSE:AZN - TradingView

Dec 23, 2024
pulisher
Aug 06, 2024

Contrast Security Introduces Application Detection and Response (ADR) to Identify and Block Attacks and Zero Days on Applications in Production - Business Wire

Aug 06, 2024
pulisher
Jun 10, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

Jun 10, 2024
pulisher
Mar 31, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 31, 2024
pulisher
Jan 04, 2024

Innate Pharma (IPHA) Gains as FDA Lifts Hold on Lymphoma Study - Zacks Investment Research

Jan 04, 2024
pulisher
Dec 12, 2022

Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286 - Business Wire

Dec 12, 2022
pulisher
Apr 29, 2022

Innate Pharma Gets $50 Million From AstraZeneca as Monalizumab Phase 3 Lung Cancer Trial Begins - Equities.com

Apr 29, 2022
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Nov 01, 2019

Innate Pharma (IPHA) Stock Price, News & Analysis - MarketBeat

Nov 01, 2019

Innate Pharma Adr (IPHA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.01
price up icon 1.80%
$35.71
price down icon 0.18%
$22.83
price up icon 0.62%
$96.88
price down icon 0.67%
$111.47
price up icon 0.91%
biotechnology ONC
$243.50
price up icon 0.85%
大文字化:     |  ボリューム (24 時間):